Dasatinib suppresses atherosclerotic lesions by suppressing cholesterol uptake in a mouse model of hypercholesterolemia

• मुख्य लेखकों: Masamitsu Takaba (लेखक), Takayuki Iwaki (लेखक), Tomohiro Arakawa (लेखक), Takaaki Ono (लेखक), Yuichiro Maekawa (लेखक), Kazuo Umemura (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Elsevier, 2022-07-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Although the use of BCR-ABL1 tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia is known to cause vascular adverse events (VAEs), the frequency of VAEs during dasatinib administration is not high, and the same holds for atherosclerosis-related VAEs. However, its effect on atherosclerosis...